BSI is delighted to announce the formation of a new technical Conformity Assessment team focusing on Medicinal Products and Biologics. Dr Jennifer Durrant has taken up the position of Global Head, Medicinal and Biologics Team. Dr Durrant worked on the BSI General Devices Team for over nine years prior to this, and has a wealth of experience and success in many of the areas within the scope of the new team.
Our experience in Medicinal Drug Consultations
2019 was a year of firsts for BSI, and 2020 kicks off with another fantastic achievement as we become the first ever to issue a Notified Body Opinion to a manufacturer for a drug-device combination product under MDR Article 117. This is thanks to the team for working incredibly hard to provide this expertise to our clients. Read more on this article.